Objective: The aim of the study is to evaluate the effect of moderate Sicilian red wine consumption on cardiovascular risk factors and, in particular, on some inflammatory biomarkers. Methods: A total of 48 subjects of both sexes who were nondrinkers or rare drinkers of moderate red wine were selected and randomly subdivided into two groups assigned to receive with a crossover design a Sicilian red wine (Nero d'Avola or Etna Torrepalino) during meals: Group A (n ¼ 24), in whom the diet was supplemented for 4 weeks with 250 ml/day of red wine, followed by 4 weeks when they returned to their usual wine intake; and Group B (n ¼ 24), in whom the usual wine intake was maintained for 4 weeks, followed by 4 weeks when the diet was supplemented with 250 ml/day of red wine. The following were values measured in all tests: blood glucose, total and HDL-cholesterol and triglycerides, LDL-cholesterol, LDL/HDL ratio, apolipoproteins A1 and B, Lp(a), plasma C-reactive protein, TGFb1, D-Dimer, Factor VII , PAI Ag, t-PA Ag, fibrinogen, oxidized LDL Ab, total plasma antioxidant capacity. Results: At the end of the red wine intake period, LDL/HDL, fibrinogen, factor VII, plasma C-reactive protein and oxidized LDL Ab were significantly decreased, while HDL-C, Apo A1,TGFb1, t-PA, PAI and total plasma antioxidant capacity were significantly increased. Conclusions: Our results show a positive effect of two Sicilian red wines on many risk factors and on some inflammatory biomarkers, suggesting that a moderate consumption of red wine in the adult population is a positive component of the Mediterranean diet.
Introduction
Wine is an alcoholic drink that in the Mediterranean culture has not only long played an important part in meals but also has a key role (together with olive oil intake and considerable vegetable consumption) in the protective effects of the Mediterranean diet on cardiovascular diseases (Avellone et al., 2003; Carluccio et al., 2003) . The complex relationship between alcohol consumption and human health has been widely studied in recent years. Recent studies, while confirming the adverse effects of excessive alcohol consumption, have demonstrated that moderate daily wine consumption can reduce the incidence of coronary artery diseases (CAD) and, more generally, cardiovascular diseases (Rimm et al., 1991; Renaud and de Lorgeril, 1994) .
One of the greatest stimuli for the scientific study of wine consumption has been the discovery of the so-called 'French paradox'. Clinical evidence originating from epidemiological studies on cardiovascular diseases and food habits indicates a linear correlation between saturated fatty acid dietary intake and the incidence of CAD, with a decreasing trend from countries in northern Europe to the Mediterranean area (Renaud and de Lorgeril, 1994) . However, an anomaly has been pointed out in this trend, because in France, despite the high saturated fat dietary intake, there is a lower incidence of CAD, which appears to be related to alcohol intake and in particular to red wine intake (Artaud-Wild et al., 1993; Kondo et al., 1994) .
Among wines, red wine appears to have a more protective effect, as it contains antioxidant substances liberated from the grape skin and seeds. In the making of white wine, these are immediately removed from the must, which is left to ferment without the solid parts of the grapes. The chemical analysis of wine makes it possible to identify certain substances considered to be responsible for this protective effect: polyphenols, in particular, including epicatechin and quercetin and, to a lesser extent, trans-resveratrol (Frankel et al., 1993a, b; Hertog et al., 1993; Pace-Asciak et al., 1995) .
On the basis of these considerations, and in relation to Sicilian wines and vine species (Gebbia et al., 2003) , we hypothesized that Sicilian red wines might also play a protective role in the prevention of CAD. The protective mechanisms would appear to be independent of the effect of equivalent aliquots of the wine's alcohol content but instead to be due to particular features of the vine species and to the polyphenol content (flavonoids, trans-resveratrol and polymeric tannins), the concentration of which is closely related to the wine-making technique (Kondo et al., 1994) . It is known that cytokines and acute phase proteins play an important role in modulating inflammatory and proliferative responses, including atherosclerosis. Transforming growth factor-beta 1 (TGFb1) and high-sensitivity C-reactive protein (hs-CRP) are major anti-inflammatory and proinflammatory markers, respectively. For the above reasons, we take into consideration the effects on some cardiovascular risk factors and, in particular, on inflammatory biomarkers (TGFb1 and hs-CRP) induced by the intake of 250 ml per day of a Sicilian red wine (Nero d'Avola or Etna Torrepalino) during meals.
Methods
A total of 48 individuals, all apparently healthy, aged between 35 and 65 years (average age 43.6710.6 years, male subjects ¼ 28 and female subjects ¼ 20, body mass index (BMI) ¼ 23.672.5 kg/m 2 ), nondrinkers or rare moderate wine drinkers (o250 ml per week), attending the lipid and thrombosis Centre of the Internal Medicine Department of the University of Palermo, Palermo, Italy, were enrolled. Obese persons (BMI 430 kg/m 2 ) and those practising active sports activity or with incorrect food habits were excluded. This evaluation was performed by a food interview by dietitians and by the establishment of food, energy and nutrient intake by means of a weekly diary (7 days food record). None of the individuals had a history of acute or chronic CAD, severe liver or kidney diseases, alterations of glycaemic (with blood glucose 4110 mg/%) or lipid metabolism (with total cholesterol 4240 mg/% or triglycerides 4200 mg/%) or current therapy with antiplatelet, anticoagulant or hypolipidaemic drugs. The women were not on oral contraceptives. All persons with high plasma homocysteine levels or with vitamin B 12 and/or folate deficiency, heavy smokers or drinkers (two or more drinks per week), were also excluded. All participants gave their informed oral consent to enter the study before commencement of the investigation (according to the Helsinki declaration).
All enrolled subjects, after a clinical and instrumental examination (blood pressure, standard and during exercise E.C.G. monitoring, extracranial carotid arteries and peripheral arteries by B-mode Duplex scanning system evaluation), were randomly subdivided into two groups and were assigned to receive, with a crossover design, one of two types of a Sicilian red wine (Nero d'Avola-Rallo, 1999 or Etna Torrepalino-Solicchiata, 1999 supplied by the Sicilian Agricultural Development Bureau: Group A (n ¼ 24), whose diet was supplemented for 4 weeks with 250 ml/day of a red wine (12 with Nero d'Avola and 12 with Etna Torrepalino) during meals and for the following 4 weeks, when they returned to their usual wine intake (i.e., no drink or only occasional wine) and Group B (n ¼ 24), who for 4 weeks maintained their usual wine intake (i.e., no drink or only occasional wine only) and whose diet for the following 4 weeks was supplemented with 250 ml/day of red wine (12 with Nero d'Avola and 12 with Etna Torrepalino) during meals.
The following parameters were determined: blood glucose, total cholesterol and triglycerides (by enzyme kit methodsBoehringer Mannheim), HDL-cholesterol (HDL-C, by selective precipitation with dextran-magnesium chloride), LDL-cholesterol (LDL-C, by calculation with the Friedewald formula), LDL/HDL ratio, apolypoproteins A1 e B (Apo A1 and B, by nephelometric assay, Dade Behring, Marburg, Germany), lipoprotein(a) (Lp(a), ELISA, Technoclone, Vienna, Austria), CRP (High Sensitivity, Dade Behring), oxidized LDL antibody (ox-LDL Ab, ELISA), total antioxidant capacity (TAC) of blood plasma (estimated using the ferric reducing ability of plasma (FRAP) method) (Benzie and Strain, 1996) , TGFb1 (ELISA, E&D Systems, Minneapolis, MN, USA), D-Dimer (Turbiquant, Dade Behring), factor VII (F VII, coagulant activity, Dade Behring), plasminogen activator inhibitor antigen (PAI Ag, ELISA), tissue plasminogen activator antigen (t-PA Ag, ELISA) and fibrinogen (coagulant activity). Blood was drawn between 08:00 and 09:00 from an antecubital vein, after overnight fasting and a 24 h abstinence from smoking, alcohol and coffee, using a 1.2 mm siliconized needle without or with minimal stasis by the two-syringe technique. Blood samples for the measurements of haemostatic tests, after discarding the first 3-4 ml of blood, were collected in polypropylene tubes containing one-tenth final volume of 3.8% sodium citrate, kept on crushed ice until centrifugation (41C, 2500 g, 15 min), and plasma was stored in small aliquots at À701C until use. Laboratory tests were determined at times: À15 days and 0 (to control the inclusion and/or exclusion criteria validity), þ 4 weeks and þ 8 weeks (to check the possible effects of food modifications on the parameters examined).
Adherence was supervised by dieticians by means of a weekly diary and a food use questionnaire performed in personal conversation at times: À15 days and 0 (to control the inclusion and/or exclusion criteria validity), þ 4 weeks and þ 8 weeks (to check adhesion to the prescribed dietetic programme).
At baseline all subjects followed the typical 'Mediterranean diet' (protein 1471.1, carbohydrate 5672.3, fat 3071.5% of energy) with high dietary fibre intake (2972.2 g/die), polyunsaturated/saturated (P/S) (0.6870.1) and monounsaturated/saturated (M/S) (1.9870.25) fatty acid ratios and low cholesterol intake (224.6713.3 mg/die) and omega-6/ omega-3 fatty acid ratio (6.1671.27).
All values were expressed as mean and standard deviation (s.d.). Statistical analysis was carried out by Student's t-test for unpaired data with normal distribution according to the Kolmogorov-Smirnov test. The nonparametric Mann-Whitney U-test was used for data not normally distributed. The relationships between TGFb1 and the other parameters were analysed by nonparametric linear regression with Kendall's rank correlation coefficient. Data are expressed as mean7s.d. A value of Po0.05 was accepted as statistically significant. Backward multivariate analyses (GraphPad Software, San Diego, CA, USA) were performed to assess the predictors of TGFb1 levels.
Results
Lipid parameters after wine supplementation At the end of addition to the diet of Sicilian red wine (Table 1) , HDL-C (Po0. 01) and Apo A1 (Po0.05) both in group A (at time þ 4 weeks) and in group B (at time þ 8 weeks) were significantly increased (Table 1) . No significant change was observed in the other lipid parameters, except for LDL/HDL ratio, in which there is a significant reduction (Po0.05) both in group A (at time þ 4 weeks) and in group B (at time þ 8 weeks) after red wine intake.
Other variables after wine supplementation
The effects of two Sicilian red wines (Nero D'Avola and Etna Torrepalino) on coagulative, fibrinolytic and inflammatory parameters are shown in Table 2 .
The addition of wine to the diet induced both in group A (at time þ 4 weeks) and in group B (at time þ 8 weeks) a significant reduction of fibrinogen (Po0.01), F VII (Po0.01), CRP (Po0.005) and ox-LDL Ab (Po0.05) levels and a significant increase of t-PA (Po0.005), PAI (Po0.005) and TAC (Po0.005) levels. No significant change was observed in D-dimer levels.
During the study (data not shown) no significant change in body weight, blood pressure or diet was found in either group -these data were well-balanced throughout the period of study (carbohydrates, 56%; fats, 30%; proteins, 14%) (except for an increase, þ 7%, in total energy intake during wine supplementation). 
Associations between TGFb1 and other variables

Discussion
Many recent studies have focused on the well-known relationship between alcohol consumption and cardiovascular risk. A reduced cardiovascular mortality in subjects with moderate daily alcohol consumption compared to that of nondrinkers with or without a history of CAD has been observed (Muntwyler et al., 1998) . In the same study the evaluation of all-cause mortality found between alcohol consumption and cardiovascular events not a linear but a U-shaped correlation, with the lowest mortality in subjects with moderate alcohol consumption (about one drink per day). Albert et al. (1999) observed a reduction in the risk of sudden cardiac death correlated to alcohol consumption, also with a U-shaped relationship. The incidence of sudden cardiac death is, in fact, high in nondrinkers, decreases in drinkers (about one drink per day) and increases in drinkers of two or more drinks per day. Several recent studies, surveying wine, beer and spirits drinkers separately, have found a reduction in the risk of developing a myocardial infarction or an ictus (Sacco et al., 1999) of about 50% in habitual drinkers of any type of alcoholic drink. Some favourable effects of moderate alcohol consumption in the prevention of CAD have been confirmed by epidemiological and experimental data. It has been known for some time that alcohol intake is positively associated with cholesterol levels bound to HDL, which is known to be an antiatherogenic lipoprotein fraction. The correlation between these two parameters is substantially linear, going from nondrinkers to heavy alcohol drinkers (more than six drinks per day) (Lacko et al., 2000) . Apo A1 levels, the major HDL apolipoproteins, also respond favourably to a daily intake of alcohol (De Oliveira e Silva et al., 2000) .
The results of our study on lipoprotein fractions are consistent with various data in the literature. Both the Sicilian wines in question caused a significant increase in HDL-C and Apo A1 levels and a nonsignificant reduction in total cholesterol and LDL-C levels. This led to a significant reduction in the LDL-C/HDL-C ratio, which is an important marker of cardiovascular risk (Assmann et al., 1998) .
Alcohol consumption affects not only certain lipid parameters but also some mechanisms of blood coagulation and thrombosis. Regarding the coagulative pattern, both wines caused a reduction in fibrinogen and FVII levels, which are today considered markers of cardiovascular risk (Meade et al., 1986) . Regarding fibrinogen, which is an independent risk factor of cardiovascular diseases, Mennen et al. (1999) demonstrated an inverse correlation in females between alcohol consumption and fibrinogen levels, while in males the correlation was U-shape, that is, with the lowest fibrinogen levels between 20 and 60 g of alcohol consumption -these had the largest cardiovascular protection .
A moderate dose of alcohol is also able to favourably affect platelet aggregation, while a high dose of alcohol carries out an action that favours a thrombus. Thromboxane urinary excretion increases significantly after a heavy evening intake of alcohol (Numminen et al., 2000) . Our study supplies a possible explanation for the reduction of cardiovascular events induced by moderate alcohol consumption. It should also be noted that significant differences in platelet aggregation are reported between red and white wine, with a smaller platelet aggregation to collagen in subjects drinking red wine, probably because of the different polyphenol content in the two types of wine (Pignatelli et al., 2002) . This result is confirmed by De Lange et al. (2003) who analysed the direct effect of alcohol, red wine and red wine polyphenolic extract on ADP-induced platelet aggregation. Only red wine polyphenolic extract has an inhibitory effect on platelet aggregation, while alcohol itself does not have a direct inhibitory effect within a range of up to 0.24%.
Regarding the fibrinolytic pattern, it is known that wine has a positive action. The fibrinolytic system plays a key role in the regulation of haemostasis and thrombosis. Deficient fibrinolysis is often due to either reduced t-PA activity or increased circulating levels of PAI. In the study conducted by Ridker et al. (1994) a linear correlation was found between t-PA levels and alcohol consumption. Passing from daily drinkers of any alcoholic drink to weekly or monthly drinkers, and then to nondrinkers, t-PA concentrations decreased by 30%, inducing a larger inclination for thrombus stabilization and therefore for thrombosis. In our study, the two wines led to an increase both in t-PA and in PAI levels. It is known that, paradoxically, t-PA increase is a risk factor for cardiovascular events. However, as the increase in t-PA levels ( þ 80.8 and 74.9% after Nero D'Avola or Etna Torrepalino intake, respectively) was more marked than the increase in Effects of moderate sicilian red wine consumption G Avellone et al PAI levels ( þ 51.6 and 59.5%, respectively), the result was that there was a global activation of fibrinolysis. This can be explained by the occurrence of reduced inactive t-PA/PAI complexes in blood resulting increased free t-PA levels (Ridker et al., 1994) . The activation of fibrinolytic activity was confirmed by a significant reduction of fibrinogen levels, an acute phase reactant, and by an increase (not statistically significant) of D-dimer levels.
Together with the properties of ethylic alcohol, it is widely known that the protective role of wine is largely due to its nonalcohol component, that is, to nonvitaminic phenolic compounds with proven antioxidant activity. Several experimental studies in vitro have demonstrated that the phenolic compounds of wine can modulate resistance to human LDL oxidation; it is also widely known that LDL oxidation is one of the pathogenetic bases of atherosclerotic vascular disease (Hertog et al., 1993) . In previous studies, higher levels of ox-LDL Ab have been reported to increase the risk of CAD, while the antioxidative properties of red wine have been invoked to explain the paradox of lower cardiovascular mortality, in spite of high-fat intake, in the French population. However, the distribution of ox-LDL Ab in the unselected population and its relationship with red wine consumption are unknown. In vivo, in the study of Cartron et al. (2003) the protective effect of red wine, white wine and French champagne appears to be due to lipid parameter modifications and not to plasma antioxidant characteristics, which showed significant modifications either after a single intake or after a long-term daily intake administration (3 weeks). In our study, in contrast with these results, a reduction in ox-LDL Ab and an increase in TAC were observed after only 4 weeks of daily red wine intake. This significant result, observed in both the Sicilian wines (rich in polyphenols), may reflect a protective role in the pathogenetic mechanisms of atherosclerotic vascular disease. Our finding is confirmed by Di Bari et al. (2003) who observed a significant inverse relationship between ox-LDL-Ab and daily wine intake, possibly because of its antioxidant properties.
In addition to and independently of its antioxidant effects, consumption of polyphenol-rich food, such as red wine, enhances the production of vasodilating factors and inhibits the synthesis of vasoconstrictor factors (Stoclet et al., 2004) . It must be emphasized that both the Sicilian red wines showed a reduction in hs-CRP and an increase in TGFb eta1 levels. CRP is an acute phase protein that among the markers of inflammation is today considered an independent risk factor in the development of thromboembolic complications (Di Garbo et al., 2000) . For several years now, inflammation has been identified with a crucial phase in the early development and growth of atherosclerotic lesions, because -apart from favouring the development of platelets -it may cause their rupture (Imfof et al., 2001; Sierksma et al., 2002) . It is well known that platelet rupture is crucial in the development of acute coronary syndromes.
TGFb1 is a multifunctional cytokine that inhibits atheromatous process by inhibiting both the migration and the proliferation of smooth muscle cells and macrophages and by protecting endothelial function. It is secreted in a latent inactive form that is activated proteolytically by plasmin. In turn, plasmin is produced from plasminogen by t-PA, the production of which is blocked by competitive inhibition fron Lp(a) and PAI-1 (Stefoni et al., 2002) . Tashiro et al. (2002) suggested that plasma concentrations of TGF-b1 decreased in patients with CAD and might have prognostic significance, considering that patients with low levels of TGF-b1 had a significantly poor prognosis in terms of survival.
To the best of our knowledge, this is the first study to make a systematic analysis of the potential determinants of TGF-b1 levels. The results of multivariate analyses demonstrated significant inverse correlations between TGFb1 and age, blood glucose and Ox-LDL Ab levels, which are all related to endothelial dysfunction. In addition, only red wine consumption is significantly associated with an increase in TGFb1 levels. The low TGFb1 levels could therefore be hypothetically related to subclinical endothelial damage, suggesting that the improvement of endothelial function plays the key role among the numerous plausible mechanisms by which red wine may confer cardiovascular protection, possibly through an anti-inflammatory effect. This mechanism is in keeping with previous studies in which tumour necrosis factor alpha (TNF-alpha)-induced adhesion of monocytes to endothelial cells is virtually abolished after red wine consumption (with high polyphenolic content) but is only partially reduced after gin consumption (with low polyphenolic content) . This effect may be due to the downregulation of adhesion molecules on the monocyte surface (Estruch et al., 2004) . Nevertheless, the role of TGFb1 in atherosclerosis needs further evaluation and correlation with other known risk factors by means of longer prospective controlled studies.
Conclusion
Although this is a short-term study and the sample is not very wide, our results show the positive effect of the two Sicilian red wines taken into consideration on numerous cardiovascular risk factors and certain inflammatory biomarkers. This anti-inflammatory action of red wine may help to explain, at least in part, the link between moderate alcohol consumption and lower cardiovascular disease risk, suggesting that a moderate red wine intake is to be encouraged in the adult population (not suffering from liver diseases or in whom alcohol intake is otherwise inadvisable) as an integrative part of the Mediterranean diet (Mezzano et al., 2001; de Lorgeril et al., 2002; Goldfinger, 2003; Avellone et al., 2004) .
